A multicenter, randomized, controlled trail including 900 patients divided patients into those undergoing on-pump versus off-pump CABG. Identical heparinization and heparin reversal protocols were followed. At angiography at 6 months following CABG, graft patency was inferior after off-pump as compared to on-pump revascularization.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary disease
November 2, 2014
Saphenous vein graft failure after coronary artery bypass surgery Circulation, 10/21/2014 Clinical Article
October 22, 2014
This video shows an approach to all-arterial grafting that has been developed over the past three decades, and illustrates techniques in four patients who underwent this procedure.
October 20, 2014
In this paper, the authors aim to further understand the factors associated with vein graft failure (VGF) after CABG. They used data on 1828 participants in the PREVENT IV trial to identify patient and surgical factors associated with VGF.
October 19, 2014
In this manuscript, the authors use meta-analysis techniques to evaluate the relationship between measured coronary fractional flow reserve (FFR) and patients’ outcomes.
October 11, 2014
In a cohort of 11,922 diabetic patients undergoing CABG, the authors compare single versus bilateral internal thoracic artery grafting (BITA), complete versus incomplete revascularization, and on versus off-pump CABG. The authors conclude that BITA with complete revascularization maximizes long-term survival.
October 9, 2014
This prospective observational study compares patients with coronary artery bypass grafting on aspirin and ticagrelor (n = 173) or on aspirin and clopidogrel (n = 232). Major bleeding complications occurred in 14.5% with ticagrelor and 13.8% with clopidogrel (p=0.89).
September 15, 2014
This descriptive study presents the peri-operative and 1-year results of on-pump and off-pump surgery performed in patients enrolled in the Arterial Revascularization Trial (ART). Out of the 3102 patients randomised in the ART trial to undergo either single or bilateral mammary artery grafting, 41% had their surgery performed off-pump.
September 5, 2014
This controlled randomized trial examined the benefits of targeted PCI vs medical therapy alone for patients with stable CAD and stenosis who were found to have zones of fractional flow reserve of less than 0.8 at angiography. Patients without regions of FFR <0.8 were entered into a registry. The composite outcome was death, nonfatal MI, or urg